PharmaJet’s needle-free delivery system proves effective in published study
More than 3000 participants took part in the trial which showed that GEMCOVAC-OM administered with PharmaJet's Tropis boosts ...
Future Market Insights2h
Global Intradermal Injection Industry
Global Intradermal Injection Industry forecasted to registering 10.8% CAGR, and projected to reach US$ 10,814.47 Million by ...
Eagle-Tribune25d
PharmaJet Announces Scientific Advisory Boards and Presentation at World Vaccine Congress in Washington on April 1
PharmaJet®, a company that strives to improve the performance and outcomes of medicines with its innovative delivery systems, today announced the formation of two Scientific Advisory Boards (SAB ...
Nature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
Nature study shows delivery of a novel self-amplifying mRNA-based vaccine with Tropis directly into the dermis significantly ...
GlobalData on MSN20h
Ariel Re forms cyber risk consortium with Hiscox Re & ILS
A riel Re has joined forces with Hiscox Re & ILS to launch a new cyber catastrophe consortium to enhance coverage certainty ...
Monthly Prescribing Reference6y
Afluria Quadrivalent
May be administered by needle and syringe (≥6mos) or PharmaJet Stratis Needle-Free Injection System (18–64yrs only); see full labeling. If 2 doses, give at least 1 month apart. 6–35mos ...
Taiwan News7d
Needle Free Injection System Market CAGR of 10.50%, 2024 Key Factors, Scope of Report, Data Sources and Research Methodology by 2032
Request To Download Free Sample of This Strategic Report @- ...
Medscape10d
Cutaneous Delivery of Prophylactic and Therapeutic Vaccines: Historical Perspective and Future Outlook
Disclosure: Both authors are employed by BD (Becton Dickinson & Co.) and own shares of stock in BD. The skin is an attractive site for vaccination. Clinical trials with numerous vaccines have ...